Xeris Biopharma Holdings, Inc. (XERS)
6.58
-0.03
(-0.45%)
USD |
NASDAQ |
Feb 23, 16:00
6.57
-0.01
(-0.15%)
After-Hours: 19:59
Xeris Biopharma Holdings Market Cap : 1.092B for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.717B |
| ACADIA Pharmaceuticals, Inc. | 4.184B |
| Alnylam Pharmaceuticals, Inc. | 43.68B |
| Savara, Inc. | 1.160B |
| BioMarin Pharmaceutical, Inc. | 12.09B |
Market Cap Related Metrics
| PS Ratio | 3.947 |
| Price to Free Cash Flow | 105.32 |
| Price | 6.58 |
| Earnings Yield | -1.57% |
| Operating PE Ratio | 107.17 |